Baihe Zhimu formula attenuates the efficacy of tamoxifen against breast cancer in mice through modulation of CYP450 enzymes-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Baihe Zhimu formula attenuates the efficacy of tamoxifen against breast cancer in mice through modulation of CYP450 enzymes

Published:2019-09-04 Issue:1 Volume:19 Page:
ISSN:1472-6882
Container-title:BMC Complementary and Alternative Medicine
language:en
Short-container-title:BMC Complement Altern Med

Author:

Li Hailong,Wu Chunyu,Liu Yu,Zhang Shuo,Gao Xiufei

Funder

National Natural Science Foundation of China

Natural Science Foundation of Zhejiang Province

Chinese Medicine Research Program of Zhejiang Province

Natural Science Foundation of Shanghai

Foundation of Shanghai Municipal Commission of Health and Family Planning

Publisher

Springer Science and Business Media LLC

Subject

Complementary and alternative medicine,General Medicine

Link

http://link.springer.com/content/pdf/10.1186/s12906-019-2651-0.pdf

Reference31 articles.

1. Goetz MP, Sangkuhl K, Guchelaar H, et al. Clinical pharmacogenetics implementation consortium (CPIC) guideline for CYP2D6 and tamoxifen therapy. Clin Pharmacol Ther. 2018;103(55):770–7.

2. Davies C. GodwinJ, gray R, et al., relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials. Lancet. 2011;378(9793):771–84.

3. Tseng E, Walsky RL, Jr LR, et al. Relative contributions of cytochrome CYP3A4 versus CYP3A5 for CYP3A-cleared drugs assessed in vitro using a CYP3A4-selective inactivator (CYP3cide). Drug Metab Dispos. 2014;42(7):1163–73.

4. Desta Z, Ward BA, Soukhova NV, et al. Comprehensive evaluation of tamoxifen sequential biotransformation by the human cytochrome P450 system in vitro: prominent roles for CYP3A and CYP2D6. J Pharmacol Exp Ther. 2004;310(3):1062–75.

5. Hansten PD. The underrated risks of tamoxifen drug interactions. Eur J Drug Metab Pharmacokinet. 2018;43(5):495–508.

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Simultaneous Analysis of Thirteen Compounds in Yeokwisan Using High-Performance Liquid Chromatography–Photodiode Array Detection and Ultra-Performance Liquid Chromatography–Tandem Mass Spectrometry and Their Antioxidant Effects;Pharmaceuticals;2024-06-04

2. Modulatory Effects of Mangiferin Isolated from Aquilaria Plants on Human Cytochrome P450 Enzyme (CYP) Activities In vitro and In silico Studies;The Natural Products Journal;2023-12

3. AR/PCC herb pair inhibits osteoblast pyroptosis to alleviate diabetes‐related osteoporosis by activating Nrf2/Keap1 pathway;Journal of Cellular and Molecular Medicine;2023-08-24

4. The Potential Role of Timosaponin-AIII in Cancer Prevention and Treatment;Molecules;2023-07-19

5. A review of the botany, ethnopharmacology, phytochemistry, pharmacology, toxicology and quality of Anemarrhena asphodeloides Bunge;Journal of Ethnopharmacology;2023-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3